Cohen, A., Maraveyas, A., Beyer-Westendorf, J., Lee, A., Folkerts, K., Abdelgawwad, K., et al. (2021). Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study. THROMBOSIS RESEARCH, 206(October 2021), 1-4 [10.1016/j.thromres.2021.06.021].

Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study

Mantovani L. G.
Ultimo
2021

Articolo in rivista - Articolo scientifico
Anticoagulants; Cancer; Patient-reported outcome measures; Rivaroxaban; Venous thromboembolism;
English
2-lug-2021
2021
206
October 2021
1
4
open
Cohen, A., Maraveyas, A., Beyer-Westendorf, J., Lee, A., Folkerts, K., Abdelgawwad, K., et al. (2021). Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study. THROMBOSIS RESEARCH, 206(October 2021), 1-4 [10.1016/j.thromres.2021.06.021].
File in questo prodotto:
File Dimensione Formato  
10281-323950_VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 487 kB
Formato Adobe PDF
487 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/323950
Citazioni
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
Social impact